$PATH

Malpani Raghavendra sold $567K of PATH

Malpani Raghavendra (CPO & CTO) sold 40,464 shares of UiPath, Inc. (PATH) at $14.00 ($0.57M total) on 2026-09-17 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Malpani Raghavendra
Published Sep 21, 2026, 10:49 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 22, 2026, 12:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$PATH
Neutral
medium confidence
Mentioned
$PATH
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PATHNeutralLow
01

Why it matters

The disclosed sale is a routine liquidity event; investors typically monitor for larger or unusual insider activity.

02

Market read

Small insider sale with limited immediate market impact; serves as a data point for ongoing monitoring.

03

What to watch

Potential upcoming product launches or earnings that may offset the sale impact.

Relevance 4/10Novelty 4/10Timing: post‑market 2026‑09‑17

Background

Form 4 filing discloses insider transactions required by SEC regulations.

Company-level read

Ticker impact

$PATHNeutralMedium confidence
Context

CPO & CTO sold 40,464 shares for $566.6K via a 10b5‑1 plan on 2026‑09‑17.

Expected impact

Minor downward pressure, likely within normal volatility range.

Evidence & confidence

Sale is a routine 10b5‑1 execution by a senior officer; amount is under $1M, so market reaction is expected to be muted.

Market effects

Minimal effect on the broader RPA/software sector.

No significant regional impact.

Limited relevance to global markets.

Counterpoint

If the insider is diversifying, could indicate hidden concerns about future performance.

Key entities

  • UiPath, Inc.

    Provider of robotic process automation software.

  • Malpani Raghavendra

    Chief Product Officer & Chief Technology Officer at UiPath.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$PATHMed

UiPath Stock Steadies As AI Agent Push Meets Wall Street Caution

UiPath Inc. (NYSE: PATH) shares rose 4.5% on September 30, 2026, driven by strong enterprise automation adoption and AI growth sentiment. The stock has been trading between $12.60 and $13.00, showing signs of stabilization. UiPath reported quarterly revenue of $410.3M, gross margin of 82.6%, and net income of $36.1M. The company is shifting focus to AI agents and orchestration, with aggressive long-term targets.

$PATHMed

A Philippine Telecom’s AI Makeover Tests UiPath’s (PATH) Pitch

UiPath (PATH) announced that PLDT, a Philippine telecom, scaled its use of UiPath's AI platform, improving efficiency and saving thousands of work hours. PATH reported Q2 2027 revenue of $410M, up 13% YoY, and annual recurring revenue of $1.938B, up 12%. The company also introduced new products and reshuffled its executive team. PATH's net new ARR was $37M, and GAAP operating income was $32M, below non-GAAP figures.